摘要
目的探讨病程较长(≥3年)的糖尿病是否影响胰腺癌中肿瘤相关巨噬细胞(TAMs)的极化,以及对胰腺癌患者预后的影响。方法收集2011年至2016年在武汉大学中南医院接受胰腺癌手术的患有长程2型糖尿病或无糖尿病患者的标本83例。采用免疫组织化学法分析组织切片中CD68和CD163的表达。运用Kaplan-Meier曲线和Log-rank检验分析生存曲线,Cox回归模型进行单因素和多因素分析。结果长程2型糖尿病(DM)组的CD68^(+)TAMs(P<0.05)、CD163^(+)TAMs(P<0.01)及CD163^(+)/CD68^(+)比例(P<0.01)均高于非糖尿病(NDM)组,差异有统计学意义。长程2型糖尿病与患者的组织分化程度、局部浸润和CA19-9的水平明显相关(P均<0.05)。长程2型糖尿病和CD163^(+)/CD68^(+)比例是无复发生存期(RFS)和总生存期(OS)的独立影响因素(P均<0.05),长程2型糖尿病明显缩短患者的RFS和OS。结论长程2型糖尿病与胰腺癌的恶性程度明显相关,并吸引更多的巨噬细胞聚集于肿瘤中,这些巨噬细胞同时大量极化为M2型TAMs。长程2型糖尿病和CD163^(+)/CD68^(+)比例是RFS和OS的独立影响因素。
Objective To study whether long-term diabetes(≥3 years)affects the polarization of tumor-associated macrophages(TAMs)in pancreatic ductal adenocarcinoma(PDAC)and its impact on the prognosis of patients with PDAC.Methods A total of 83 resected specimens of patients with long-term type 2 diabetes mellitus(T2DM)or without diabetes who underwent PDAC surgery in the hospital from 2011 to 2016 were collected.The expression of CD68 and CD163 in tissue sections were analyzed by immunohistochemistry.Kaplan-Meier curve with Log-rank test was used to analyze survival curves,and Cox proportional hazard model was used for univariate and multivariate analysis.Results CD68^(+)TAMs(P<0.05),CD163^(+)TAMs(P<0.01)and CD163^(+)/CD68^(+)ratio(P<0.01)in the long-term T2DM(DM)group were higher than those in non-T2DM(NDM)group,there were statistically significant differences.Long-term T2DM was associated with poor differentiation,local infiltration and CA19-9 level(all P<0.05).Long-term T2DM and CD163^(+)/CD68^(+)ratio were independent factors of recurrence-free survival(RFS)and overall survival(OS)(both P<0.05).Long-term T2DM could significantly shorten RFS and OS of patients.Conclusion Long-term T2DM was associated with malignant level of PDAC,and attracted more macrophages to accumulate in the tumor,and most of those were simultaneously transformed into M2-like TAMs.Long-term T2DM and CD163^(+)/CD68^(+)ratio were independent factors of RFS and OS.
作者
阮勇
杨滢
徐世荣
余京洪
李炫飞
姜毅楠
胡炜
王伟
方效昌
潘雪凯
Ruan Yong;Yang Ying;Xu Shirong;Yu Jinghong;Li Xuanfei;Jiang Yinan;Hu Wei;Wang Wei;Fang Xiaochang;Pan Xuekai(Department of General Surgery,the Second Hospital of Huangshi,Huangshi 435002,China;Department of General Surgery,the People’s Hospital of Tuanfeng,Huanggang 438000,China;Department of Gastrointestinal Surgery,Zhongnan Hospital,Clinical Medical Research Center of Peritoneal Cancer of Wuhan,Clinical Cancer Study Center of Hubei Provence,Key Laboratory of Tumor Biological Behavior of Hubei Provence,Wuhan 430071,China)
出处
《中华实验外科杂志》
CAS
北大核心
2022年第10期1991-1994,共4页
Chinese Journal of Experimental Surgery
基金
国家自然科学基金(82070302、1902018)
武汉市腹膜癌临床医学研究中心资助项目(2015060911020462)
湖北省卫生健康委员会面上项目(WJ2021M167)
武汉大学中南医院科技创新培育基金资助项目(CXPY2022055)。
关键词
长程2型糖尿病
胰腺导管腺癌
肿瘤相关巨噬细胞
预后
Long-term type 2 diabetes mellitus
Pancreatic ductal adenocarcinoma
Tumor-associated macrophages
Prognosis